Is a complete CSE/VREO research report available?

No complete published report is available for cse/VREO (CSE/VREO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

cse/VREO stock profile: metrics, valuation and analysis

Market cap	812.4M
Revenue (ttm)	726.6M
Net income (ttm)	-95.3M
EPS (ttm)	-CA$2.57
Shares out	48.8M
P/E (forward)	6.5x
Volume	6,133
Beta	0.10

All CSE/VREO indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	612
Employees Change	92%
Employees Change Percent	17.69
Enterprise value	CAD 1.4B
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.36
Last refreshed	2026-09-12
Market cap	CAD 812.4M
Price	CAD 16.69
Price currency	CAD
Rev Per Employee	1,283,783.62x
Sector	Healthcare
Sic	2834
Symbol	cse/VREO
Website	https://vireogrowth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.73%
EV/EBIT	27.05x
EV/EBITDA	12.47x
EV/Sales	1.86x
FCF yield	-20.33%
Forward P/E	6.5x
P/B ratio	1.29x
P/S ratio	1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.89%
EBITDA Margin	11.89%
Gross margin	48.64%
Gross Profit	CAD 353.5M
Gross Profit Growth	330.79%
Gross Profit Growth Q	367.16%
Gross Profit Growth3 Y	88.94%
Gross Profit Growth5 Y	61.31%
Net Income	CAD -95.3M
Pretax Margin	-2.93%
Profit Margin	-13.12%
Profit Per Employee	CAD -168,390
ROA	2.28
Roa5y	-0.45
ROCE	3.99
ROE	-18.88
ROIC	5.04
Roic5y	11.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.66%
Cagr3y	28.85%
Cagr5y	-21.02%
OCF Growth Qo Q	-79.83%
Revenue Growth	316.71x
Revenue Growth Q	335.14x
Revenue Growth Qo Q	97.08x
Revenue Growth3 Y	87.86x
Revenue Growth5 Y	57.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.53
Assets	CAD 1.8B
Cash	CAD 147.8M
Current Assets	CAD 546.8M
Current Liabilities	CAD 541.5M
Debt	CAD 689.9M
Debt EBITDA	CAD 6.35
Debt Equity	CAD 1.1
Debt FCF	CAD -4.18
Equity	CAD 628.4M
Interest Coverage	1.09
Liabilities	CAD 1.2B
Long Term Assets	CAD 1.3B
Long Term Liabilities	CAD 638.9M
Net Cash	CAD -542.1M
Net Cash By Market Cap	CAD -66.72
Net Debt EBITDA	CAD 6.27
Net Debt Equity	CAD 0.86
Tangible Book Value	CAD 89M
Tangible Book Value Per Share	CAD 1.94
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	2.47
Net Working Capital	CAD -62.5M
Quick ratio	0.48
Working Capital	CAD 5.4M
Working Capital Turnover	CAD 19.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-226.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.64%
200-day SMA	18.01
3Y total return	113.97%
50-day SMA	14.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.26%
All Time High	206.1
All Time High Change	-91.9%
All Time High Date	2019-04-08
All Time Low	3.9
All Time Low Change	327.95%
All Time Low Date	2023-03-30
ATR	0.54
Beta	0.1
Beta1y	0.67
Beta2y	-0.4
Ch YTD	-32.97
High	16.8
High52	31.5
High52 Date	2025-10-15
High52ch	-47.02%
Low	16.69
Low52	12.57
Low52 Date	2026-06-29
Low52ch	32.78%
Ma50ch	15.14%
Price vs 200-day SMA	-7.33%
RSI	65.82
RSI Monthly	46.38
RSI Weekly	50.08
Sharpe ratio	0.11x
Sharpe Ratio3y	0.82x
Sharpe Ratio5y	0.31x
Sortino ratio	0.23
Sortino Ratio3y	1.47
Sortino Ratio5y	0.56
Total Return	-226.25%
Tr YTD	-32.97
Tr1m	16.71%
Tr1w	11.56%
Tr3m	-8.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,108,267%
Net Borrowing	105,559,935.2
Shares Insiders	11.26%
Shares Institutions	9.19%
Shares Out	48,821,377
Shares Qo Q	25.19%
Shares Yo Y	226.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -196.3M
Adjusted OCF	6,056,419
Average Volume	21,477.8x
Bv Per Share	13.72
CAPEX	CAD -202.4M
Ch1m	16.71
Ch1w	11.56
Ch1y	-21.64
Ch3m	-8.8
Ch3y	114
Ch5y	-69.26
Ch6m	-4.08
Change	-0.95%
Change From Open	-0.36
Close	16.85
Days Gap	-0.59
Depreciation Amortization	35,462,433
Dollar Volume	102,359.8
Earnings Date	2026-11-11
EBIT	CAD 50.1M
EBITDA	CAD 86.4M
EPS	CAD -2.57
F Score	5
FCF	CAD -165.2M
FCF EV Yield	-12.2x
FCF Per Share	CAD -3.38
Financing CF	108,238,686
Fiscal Year End	December
Founded	2,004
Goodwill	223,292,655
Income Tax	CAD 74M
Investing CF	-121,902,164
Is Primary Listing	1
Last Earnings Date	2026-08-11
Last Report Date	2026-06-30
Last Split Date	2026-06-05
Last Split Type	Reverse
Ma150	16.59
Ma150ch	0.61%
Ma20	15.33
Ma20ch	8.85%
Net CF	23,559,460
Next Earnings Date	2026-11-11
Open	16.75
P OCF Ratio	21.82
P OCF Ratio SBC	134.1
Position In Range	0
Ppne	602,377,330
Price Date	2026-09-10
Price EBITDA	CAD 9.4
Ptbv Ratio	9.12
Relative Volume	0.29x
Revenue	726,621,527x
SBC By Revenue	4.29x
Share Based Comp	31,166,519
Tax By Revenue	10.18x
Tr6m	-4.08%
Volume	6,133
Z Score	0.55

CSE/VREO (CSE/VREO)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/VREO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/VREO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/VREO

Frequently asked questions